Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex

Consciousness and Cognition

Volumn 11, Issue 3, 2002, Pages 461-474

  Ballard, Clive G ^a   Court, Jennifer A ^a   Piggott, Margaret ^a   Johnson, Mary ^a   O'Brien, John ^a   McKeith, Ian ^a   Holmes, Clive ^b   Lantos, Peter ^c   Jaros, Evelyn ^a   Perry, Robert ^a   Perry, E ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b MOORGREEN HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bungarotoxin binding; Choline acetyl transferase; Consciousness; Dementia; Epibatidine binding; Lewy bodies; M1 muscarinic receptor; Nicotinic receptors; Temporal cortex

Indexed keywords

ALPHA BUNGAROTOXIN; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; EPIBATIDINE; IODINE 125; MUSCARINIC M1 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; NICOTINIC RECEPTOR; PIRENZEPINE; PROCYCLIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRITIUM;

AGED; ARTICLE; ATTENTION; AWARENESS; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; FEMALE; HUMAN; LEWY BODY; MALE; PATHOLOGY; PROTEIN BINDING; SYMPTOMATOLOGY; TEMPORAL CORTEX;

AGED; BUNGAROTOXINS; CONSCIOUSNESS DISORDERS; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; RECEPTORS, NICOTINIC; TEMPORAL LOBE;

EID: 0036761007     PISSN: 10538100     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-8100(02)00013-2     Document Type: Article

References (47)

1. Alkondon, M., & Albuquerque, E. X. (1995). Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. Journal of Pharmacology and Experimental Therapeutics, 274, 771-782.
2. Alkondon, M., Pereira, E. F., Barbosa, C. T., & Albuquerque, E. X. (1997). Neuronal nicotinic acetylcholine receptor activation modulates γ-aminobutyric acid release from CA1 neurons of rat hippocampal slices. Journal of Pharmacology and Experimental Therapeutics, 283, 1396-1411.
3. Ballard, C. G., McKeith, I. G., & Ayre, G., et al. (2000a). Impairments in attention and fluctuating attention distinguish between dementia with Lewy bodies and Alzheimer's disease (Abstract). Neurology, 54(Suppl. 3), A451.
4. Ballard, C., Piggott, M., Johnson, M., Cairns, N., Perry, R., McKeith, I., Jaros, E., O'Brien, J., Holmes, C., & Perry, E. (2000b). Delusions are associated with elevated muscarinic binding in dementia with Lewy bodies. Annals of Neurology, 48, 867-868.
5. Ballard, C., McKeith, I., Burns, D., Harrison, R., O'Brien, J., Lowery, K., Campbell, M., Perry, R., & Ince, P. (1997). The UPDRS scale is a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurologica Scandinavica, 96, 366-371.
6. Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathology, 82, 239-259.
7. Brizer, D. A., & Manning, D. W. (1982). Delerium induced by poisoning with anticholinergic agents. American Journal of Psychiatry, 139, 1343-1344.
8. Byrne, E. J., Lennox, G., Lowe, J., & Godwin-Austen, R. B. (1989). Diffuse Lewy body disease: Clinical features in 15 cases. Journal of Neurological and Neurosurgical Psychiatry, 52, 709-717.
9. Clarke, P. B. S. (1992). The fall and rise of neuronal α-bungarotoxin binding proteins. Trends in Pharmacological Science, 13, 407-413.
10. 3H]-dopamine release. British Journal of Pharmacology, 117, 595-606.
11. Cummings, J. L., & Benson, D. F. (1992). Dementia: Definition, prevalence, classification and approach to diagnosis. In J. L. Cummings & D. F. Benson (Eds.). Dementia: A Clinical Approach. Boston: Butterworth-Heineman.
12. Desmedt, J. E., & Tomberg, T. (1995). Consciousness. Electroencephalography and Clinical Neurophysiology, 44, 227-234.
13. Devanand, D. P., Miller, L., Richards, M., Marder, K., Bell, K., Mayeux, R., & Stern, Y. (1992). The Columbia University scale for psychopathology in Alzheimer's disease. Archives of Neurology, 49, 371-376.
14. Dewey, M. E., Copeland, J. R. M., Lobo, A., Saz, P., & Dia, S. L. (1992). Computerised diagnosis from a standardised history schedule: A preliminary communication about the organic section of the HAS-AGECAT system. International Journals of Geriatric Psychiatry, 7, 443-446.
15. Flood, P., Ramirez-Latorre, J., & Role, L. (1997). α 4 β 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurene and propofol but α 7 type nicotinic receptors are unaffected. Anesthiology, 86, 859-865.
16. Flores, C. M., Dávila-García, M., Ulrich, Y. M., & Kellar, K. J. (1997). Differential regulation of neuronal receptor binding sites following chronic nicotine administration. Journal of Neurochemistry, 69, 2216-2219.
17. Flugel, F., & Itil, T. (1966). Anticholinergic drug induced delerium: Experimental modification, quantitative EEG and behavioural correlations. Journal of Nervous and Mental Diseases, 143, 492-507.
18. Gray, A., & Fann, P. (1993). Alzheimer's disease: The burden of illness in England. Health Trends, 20, 31-37.
19. Gibb, W. R. G., Esiri, M. M., & Lees, A. J. (1987). Clinical and pathological features of diffuse Lewy body disease (Lewy body dementia). Brain, 110, 1131-1153.
20. Grober, E., Gitlin, H., Bang, S., & Buschke, H. (1992). Implicit and explicit memory in young, old and demented adults. Journal of Clinical and Experimental Neuropsychology, 14, 298-316.
21. Guan, Z.-Z., Zhang, X., Ravid, R., & Nordberg, A. (2000). Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. Journal of Neurochemistry, 74, 237-243.
22. Jones, G., Sahakian, B., Levy, R., Warburton, D., & Gray, J. (1992). Effects of acute subcutaneous nicotine on attention, information processing, and short-term memory in Alzheimer's disease. Psychopharmacology, 108, 485-494.
23. Karczmar, A. G. (1993). Comments to session on electrophysiological aspects of cholinergic mechanisms. Progress in Brain Research, 98, 279-284.
24. Kaufer, D. I., Catt, K. A., Lopez, O. L., & DeKosky, S. T. (1998). Dementia with Lewy bodies: Response of delirium-like features to donepezil. Neurology, 15, 1512.
25. Kolbeinsson, H., & Jonsson, A. (1993). Delirium and dementia in acute medical admissions of elderly patients in Iceland. Acta Psychiatrica Scandinavica, 87, 123-127.
26. Martin-Ruiz, C., Court, J., Lee, M., Piggott, M., Johnson, M., Ballard, C., Kalaria, R., Perry, R., & Perry, G. (2000). Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types. Acta Neurolica Scandinavica, 102, 1-8.
27. Martin-Ruiz, C. M., Court, J. A., Molnar, E., Lee, M., Gotti, C., Mamalaki, A., Tsouloufis, T., Tzartos, S., Ballard, C., Perry, R., & Perry, G. (1999). α4 but not α3 or α7 Nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. Journal of Neurochemistry, 73, 635-1640.
28. McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., Lennox, G., Quinn, N. P., Edwardson, J. A., Ince, P. G., Bergerson, C., Burns, A., Miller, B. L., Lovestone, S., Collerton, D., Janson, E. N., Ballard, C, de Vos, R. A., Wilcock, G. K., Jellinger, K. A., & Perry, R. H. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Neurology, 47, 1113-1124.
29. McKeith, L., Del Ser, T., Anand, R., Cicin-Sain, A., & Spiegel, R. (2000). Rivastigmine provides symptomatic benefit & dementia with Lewy bodies: Findings from a placebo controlled international multi-center study. Neurology, 54, A450 [Abstract].
30. Mirra, S. S., Heyman, A., McKell, D., and Participating CERAD Neuropathologists: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) II. (1991). Standardisation of the neuropathological assessment of Alzheimer's disease. Neurology 41, 479-486.
31. Newhouse, P., Sunderland, T., & Tariot, P. N., et al. (1988). The effect of acute scopolamine in geriatric depression. Archives of General Psychiatry, 45, 906-912.
32. Newhouse, P., Potter, A., & Corwin, J. (1996). Effects of nicotinic cholinergic agents on cognitive functioning in Alzheimer's and Parkinson's disease. Drug Development Research, 38, 278-289.
33. Pearlin, L. I., Mullen, J. T., Semple, S. J., & Skaff, M. M. I. (1990). Caregiving and the stress process. An overview of concepts and their measures. Gerontology, 30, 583-594.
34. Perry, E. K., Johnson, M., Kerwin, J., Piggott, M. A., Court, A., Ince, P. G., Shaw, P., & Perry, R. H. (1992). Convergent artichortical cholinergic activities in ageing and Alzheimer's disease. Neurobiology of Ageing, 13, 393-400.
35. Perry, E. K., Walker, M. P., Grace, J., & Perry, R. (1999). Acetylcholine in mind: A neurotransmitter correlate of consciousness. Trends in Neuroscience. 22, 273-280.
36. Perry, E. K., Haroutunian, V., Davis, K., Levy, R., Lantos, P., Eagger, S., Mrinalini, H., Dean, A., Griffiths, M., McKeith, I. G., & Perry, R. H. (1994). Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuro Report, 5, 745-747.
37. Perry, R. H., Irving, D., Blessed, G., Fairbairn, A., & Perry, E. K. (1990). A clinically & pathologically distinct form of Lewy body dementia in the elderly. Journal of Neurological Science, 95, 119-139.
38. Prusky, G. T., Shaw, C., & Cynader, M. S. (1987). Nicotine receptors are located on lateral geniculate nucleus terminals in cat visual cortex. Brain Research, 412, 131-138.
39. Roth, M., Tym, E., & Mountjoy, C., et al. (1986). CAMDEX; A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry, 149, 698-709.
40. Sahin, M., Bowen, W. D., & Donoghue, J. P. (1992). Location of nicotinic and muscarinic cholinergic and mu-opiate receptors in rat cerebral neocortex: Evidence from thalamic and cortical lesions. Brain Research, 579, 135-147.
41. Schröder, H., Zilles, K., Maelicke, A., & Hajos, F. (1989). Immunohisto- and cytochemical localization of cortical nicotinic cholinoceptors in rat and man. Brain Research, 502, 287-295.
42. Sparks, D. L., Beach, T. G., & Lukas, R. J. (1998). Immunohistochemical localization of nicotinic β 2 and α 4 receptor subunits in normal human brain and in individuals with Lewy body and Alzheimer's disease: Preliminary observations. Neuroscience Lettters, 256, 151-154.
43. Tune, L. E., Damlouji, N. F., Holland, A., Gardner, T. J., Folstein, M. F., & Coyle, J. T. (1981). Association of post-operative delerium with raised serum levels of anticholinergic drugs. Lancet, 2, 651-652.
44. Walker, M. P., Ayre, G. A., Cummings, J. L., Wesnes, K., McKeith, I. G., O'Brien, J. T., & Ballard, C. G. (2000a). Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease and vascular dementia. Neurology, 54, 1616-1625.
45. Walker, M. P., Ayre, G. A., Cummings, J. L., Wesnes, K., McKeith, I. G., O'Brien, J. T., & Ballard, C. G. (2000b). The clinician assessment of fluctuation and the one day fluctuation assessment scale: Two methods to assess fluctuating confusion in dementia. British Journal of Psychiatry, 177, 252-256.
46. Wilkie, G. I., Hutson, P., Sullivan, J. P., & Wonnacott, S. (1996). Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurchemical Research, 21, 1141-1148.
47. Woolf, N. J. (1997). A possible role for cholinergic neurons of the basal forebrain and pontomesencephalon in consciousness. Consciousness and Cognition, 6, 574-596.